BRIEF published on 11/12/2024 at 09:21, 10 days 23 hours ago New Appointments Strengthen Leadership at Compagnie des Alpes Executive Committee Compagnie Des Alpes Strategic Growth Rémi Fournial Aymeric Noizet
BRIEF published on 11/12/2024 at 09:18, 10 days 23 hours ago Compagnie des Alpes: Appointments to the Executive Committee Appointments Executive Committee Company Of The Alps Rémi Fournial Aymeric Noizet
REGULATED PRESS RELEASE published on 11/12/2024 at 09:16, 10 days 23 hours ago CDA - Appointements to the Executive committee Compagnie des Alpes appoints Rémi Fournial as Director of Strategy and Development and Aymeric Noizet as Chief Information and Digital Officer to the Executive Committee. Company overview and upcoming events included Appointments Executive Committee Compagnie Des Alpes Strategy Digital Officer
BRIEF published on 10/22/2024 at 17:50, 1 month ago Compagnie des Alpes Reports Strong Fiscal Year 2023/24 Sales Growth Compagnie Des Alpes Fiscal Year 2023/24 Annual Sales Growth Ski Areas Division Leisure Parks Performance
BRIEF published on 10/22/2024 at 17:45, 1 month ago Performance 2023/24: Growth and Records for Compagnie des Alpes Ski Areas Growth Urban Group Amusement Parks Turnover 2023/24
REGULATED PRESS RELEASE published on 10/22/2024 at 17:45, 1 month ago CDA - FY 2023 2024 sales Compagnie des Alpes reports €1,239M annual sales for 2023/24 financial year, up 10.1%. Strong performance in Ski Areas, Leisure Parks, and Distribution & Hospitality divisions. Annual EBITDA target around €350M confirmed Compagnie Des Alpes Financial Year 2023/24 Sales Growth EBITDA Target Divisions Performance
BRIEF published on 10/11/2024 at 18:16, 1 month 11 days ago Changes in Compagnie des Alpes Board of Directors Board Of Directors Financial Statements Compagnie Des Alpes Appointment Martine Gerow
BRIEF published on 10/11/2024 at 18:13, 1 month 11 days ago Changes to the Board of Directors of Compagnie des Alpes Board Of Directors Appointment Company Of The Alps Martine Gerow Savings Bank
REGULATED PRESS RELEASE published on 10/11/2024 at 18:11, 1 month 11 days ago CDA - CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS Compagnie des Alpes appoints Martine Gerow as independent director following the resignation of Caisse d'Epargne Rhône-Alpes. Changes in the Board composition to be ratified at the next General Meeting Board Of Directors Compagnie Des Alpes General Meeting Martine Gerow Caisse D'Epargne Rhône-Alpes
BRIEF published on 10/10/2024 at 17:48, 1 month 12 days ago Dominique Thillaud Reappointed as CEO of Compagnie des Alpes Board Of Directors Financial Results Compagnie Des Alpes Dominique Thillaud CEO Reappointment
Published on 11/22/2024 at 23:55, 9 hours 17 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 42 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 7 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 42 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 57 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 18 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 16 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 12 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024